Tapentadol

Details

Files

Generic Name:

Tapentadol

Project Status:

Complete

Therapeutic Area:

Pain, moderate to moderately severe

Manufacturer:

Janssen Inc.

Call for patient/clinician input open:

January 20, 2011

Brand Name:

Nucynta CR

Project Line:

Reimbursement Review

Project Number:

SR0224-000

Call for patient/clinician input closed:

February 24, 2011

NOC Status at Filing:

Post NOC

Submission Type:

Initial

Indications:

Pain, moderate to moderately severe

Recommendation Type:

Do not list

Final Recommendation:

September 28, 2011

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Plain Language Recommendation View PDF

Last Updated : February 1, 2011